Health and Safety Reminders
Wednesday Collaboration
Thursday Afternoon
Board Appreciation Month
PAINE PRECEPTS
COVID Vaccine Resources
Alabama Dept of Health—COVID-19 Vaccine
Table of Contents
- Vaccine Status
- News Releases
- Planning and Distribution
- Prioritization and Availability
- Why Should You Get Vaccinated?
- Vaccine Safety
- How the COVID-19 Vaccine Works
- Side Effects
- COVID-19 Vaccine Resources
- Finding Credible Vaccine Information
For provider information regarding vaccinations, visit COVID-19 Vaccination Provider Support.
For frequently asked questions regarding COVID-19 vaccine, visit COVID-19 Vaccine FAQ.
For data on vaccination allocation and administration in Alabama, visit the COVID-19 Vaccine Distribution Dashboard.
Vaccine Status
Two vaccines have been authorized for emergency use by U.S. Food & Drug Administration (FDA).
Pfizer-BioNTech COVID-19 Vaccine: The vaccine is authorized for emergency use in persons aged 16 years and older. This is a two-dose vaccine, given 21 days apart. Clinical trial data show the vaccine is 95 percent effective at preventing COVID-19 infection starting seven days after the second dose. Individuals will not be considered fully protected until one to two weeks after they receive the second dose. The clinical trials revealed no major unanticipated adverse events. This vaccine arrived in Alabama on December 14.
Moderna COVID-19 Vaccine: This vaccine is authorized for emergency use in individuals aged 18 years and older. This is a two-dose vaccine, given 28 days apart. Clinical trial data shows the vaccine is about 94 percent effective after two doses. No serious safety concerns were found. This vaccine arrived in Alabama on December 21.
Multiple COVID-19 vaccines are also still under development. Large-scale (Phase 3) clinical trials are in progress or being planned for two additional COVID-19 vaccines in the United States.
Planning and Distribution
The Alabama Department of Public Health (ADPH) is putting everything in place to distribute and administer vaccine doses as quickly as possible, but only after vaccine safety has been reviewed and approved by a panel of top health experts. ADPH is currently working to pre-position COVID-19 vaccine in several locations statewide to ensure equitable and timely distribution to federally designated critical populations.
Current federal funding will support partnerships with local health jurisdictions and tribal entities, mass vaccination clinics, vendor contracts, and staffing. ADPH has redirected some current staff to this program and is hiring additional positions to support this work.
ADPH submitted its COVID-19 Vaccination Plan to the Centers for Disease Control and Prevention (CDC). The goal of the plan is to immunize everyone who is eligible to receive a COVID-19 vaccine.
Prioritization and Availability (As of January 4)
The Alabama Department of Public Health (ADPH) knows that many Alabamians are interested in receiving the COVID-19 vaccine as soon as it is available to their risk group. As the supply of COVID-19 vaccine is limited at the moment, ADPH is following the guidance of the Advisory Committee on Immunization Practices (ACIP) for prioritization of risk groups.
View the Alabama COVID‐19 Vaccination Allocation Plan(Revised 01/06/21) which defines populations and the order in which they will receive vaccine in four phases. Note: This document is a draft and will be updated as additional guidance from the Advisory Committee on Immunization Practices (ACIP) is available.
Alabama has had COVID-19 vaccine in our state for three weeks. As of January 4, there have been 42,810 vaccine doses administered out of our initial allocation of 226,250 doses. See our COVID-19 Vaccine Distribution Dashboard. Alabama is in Phase 1a, consisting of 300,000 healthcare workers. The week of December 28, residents of Long-Term Care began vaccination through the federal Pharmacy Partnership.
Some counties have been able to intermittently vaccinate persons age 75 years and older once the uptake of vaccine for Phase 1a has been satisfied for a daily clinic. ADPH will continue to work with community partners to vaccinate persons in Phase 1a and, as supply allows, persons 75 years and above.
Once persons in Phase 1a have been administered or offered the vaccine, Alabama will move into Phase 1b. ADPH does not have a timeline on this as ability to move to the next Phase is dependent on vaccine supply.
When Alabama moves to Phase 1b, ADPH will send notices to doctors, pharmacies, urgent cares, rural health clinics, and other providers so they can advise their patients. ADPH will also provide information through various outlets including social media, news releases, and other coverage. This notification will happen with subsequent phases as well.
The Medical Association of the State of Alabama provides a list of Phase 1a physician categories that have been prioritized for the initial doses and vaccine clinic locations with appointment dates and times on their Resources for Physicians website and Vaccine for Providers toolkit.
The vaccine will be free to all Americans. ADPH has no specific timetable about when members of the general public can be vaccinated. As the supply of vaccine remains limited, ADPH continues to urge the public to practice the measures needed to help reduce the transmission of COVID-19. Alabama residents should continue to exercise caution by minimizing travel and avoiding gatherings of people beyond their immediate household.
Even if you get vaccinated, we recommend you continue with the other prevention measures, such as washing your hands, wearing a mask, staying six feet apart, and limiting gatherings. Visit Prevention and Treatment for more information.
No comments:
Post a Comment